LEXINGTON, Mass.--(BUSINESS WIRE)--RainDance Technologies, Inc., a private company pioneering microdroplet-based technologies for single-molecule and single-cell analysis, today announced that it will present at two upcoming investor conferences in September: the Stifel Nicolaus Healthcare Conference and the UBS Global Life Sciences Conference.
